Riociguat Is a Novel Medication for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Medical Council
doi 10.21518/2079-701x-2016-4-20-27
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Remedium, Ltd.

Related search

Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Pathophysiology

European Respiratory Review
PulmonaryRespiratory Medicine
2010English

Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center

Cardiology and Therapy
2015English

Chronic Thromboembolic Pulmonary Hypertension

2010English

Chronic Thromboembolic Pulmonary Hypertension

Seminars in Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2009English

Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Chronic Thromboembolic Pulmonary Hypertension

2020English

Chronic Thromboembolic Pulmonary Hypertension

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2015English

Balloon Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension: Is Europe Behind?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2019English

New Possibilities in the Treatment of Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension in Ukraine

HYPERTENSION
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy